title: ONTARGET ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial A Large, Simple Randomized Trial of an Angiotensin II Receptor Antagonist (Telmisartan) and an ACE-Inhibitor (Ramipril) in Patients at High Risk for Cardiovascular Events and TRANSCEND Telmisartan Randomized AssessmeNt Study in aCE iNtolerant Subjects With Cardiovascular Disease. A Parallel Study Comparing the Effects of Telmisartan With Placebo and Outcomes in Patients at High Risk for Cardiovascular Events and Intolerant to ACE-I.

summary:
The Ongoing Telmisartan Alone and in combination wiht Ramipril Global Endpoint trial (ONTARGET): The primary objectives are to determine if (a) telmisartan 80mg daily and ramipril 10mg daily combination therapy is more effective in reducing the composite endpoint of Cardiovascular Death (CV) death, Myocardial infarction (MI), stroke or hospitalization for Congestive Heart Failure (CHF) compared with ramipril 10mg alone; and (b) telmisartan 80mg daily is at least as effective as (i.e. not less effective than) ramipril 10mg daily, on this endpoint.

Telmisartan Randomised Assessment Study in Angiotension converting Enzyme inhibitor intolerant subjects with Cardiovascular Disease. (TRANSCEND): The primary objective of the study is to determine if treatment with telmisartan 80mg daily is superior to placebo reducing the composite endpoint of Cardiovascular Death (CV), Myocardial Infarction ( MI)I, stroke or hospitalization for Congestive Heart Failure (CHF) in patients who are intolerant to Angiotension Converting Enzyme inhibitors.

ReferenceCitation: Bohm M, Schumacher H, Werner C, Teo KK, Lonn EM, Mahfoud F, Speer T, Mancia G, Redon J, Schmieder RE, Sliwa K, Marx N, Weber MA, Laufs U, Williams B, Yusuf S, Mann JFE. Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk. Cardiovasc Diabetol. 2022 Jan 20;21(1):12. doi: 10.1186/s12933-021-01429-w.

repository_institution: University of Cape Town - Open University of Cape Town

repository_normalized: localhost

repository_institution: Kooperativer Bibliotheksverbund Berlin-Brandenburg - OPUS Repository

repository_institution: Saarland University and State Library - SciDok

evidence: oa repository (via OAI-PMH title and last author match)

repository_institution: University College London - UCL Discovery

repository_normalized: UCL Discovery

repositories_institution: Saarland University and State Library - SciDok

repositories_institution: University College London - UCL Discovery

ReferenceCitation: Bohm M, Schumacher H, Teo KK, Lonn EM, Lauder L, Mancia G, Redon J, Schmieder RE, Sliwa K, Marx N, Weber MA, Williams B, Yusuf S, Mann JFE, Mahfoud F. Cardiovascular outcomes in patients at high cardiovascular risk with previous myocardial infarction or stroke. J Hypertens. 2021 Aug 1;39(8):1602-1610. doi: 10.1097/HJH.0000000000002822.

ReferenceCitation: Bohm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Emrich I, Mancia G, Redon J, Schmieder RE, Sliwa K, Lehrke M, Marx N, Weber MA, Williams B, Yusuf S, Mann JFE. Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk. J Hypertens. 2021 Apr 1;39(4):766-774. doi: 10.1097/HJH.0000000000002697.

ReferenceCitation: Mancia G, Schumacher H, Bohm M, Mann JFE, Redon J, Facchetti R, Schmieder RE, Lonn EM, Teo KK, Yusuf S. Visit-to-visit blood pressure variability and renal outcomes: results from ONTARGET and TRANSCEND trials. J Hypertens. 2020 Oct;38(10):2050-2058. doi: 10.1097/HJH.0000000000002567.

ReferenceCitation: Dehghan M, Mente A, Rangarajan S, Mohan V, Lear S, Swaminathan S, Wielgosz A, Seron P, Avezum A, Lopez-Jaramillo P, Turbide G, Chifamba J, AlHabib KF, Mohammadifard N, Szuba A, Khatib R, Altuntas Y, Liu X, Iqbal R, Rosengren A, Yusuf R, Smuts M, Yusufali A, Li N, Diaz R, Yusoff K, Kaur M, Soman B, Ismail N, Gupta R, Dans A, Sheridan P, Teo K, Anand SS, Yusuf S. Association of egg intake with blood lipids, cardiovascular disease, and mortality in 177,000 people in 50 countries. Am J Clin Nutr. 2020 Apr 1;111(4):795-803. doi: 10.1093/ajcn/nqz348.

oa_colors: green hybrid

license: elsevier-specific: oa user license

license_normalized: elsevier-specific

repository_institution: Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia

repository_institution: North-west University - Boloka Institutional Repository

ReferenceCitation: Bohm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Mann JFE, Mancia G, Redon J, Schmieder RE, Marx N, Sliwa K, Weber MA, Williams B, Yusuf S. Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk. Eur Heart J. 2019 Jul 1;40(25):2032-2043. doi: 10.1093/eurheartj/ehz149.

ReferenceCitation: Bohm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Ukena C, Mann JFE, Mancia G, Redon J, Schmieder RE, Sliwa K, Marx N, Weber MA, Williams B, Yusuf S. Resting heart rate and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk analysis from the ONTARGET/TRANSCEND trials. Eur Heart J. 2020 Jan 7;41(2):231-238. doi: 10.1093/eurheartj/ehy808.

ReferenceCitation: Bohm M, Schumacher H, Teo KK, Lonn EM, Mahfoud F, Mann JFE, Mancia G, Redon J, Schmieder RE, Sliwa K, Weber MA, Williams B, Yusuf S. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Lancet. 2017 Jun 3;389(10085):2226-2237. doi: 10.1016/S0140-6736(17)30754-7. Epub 2017 Apr 5.

ReferenceCitation: Dunkler D, Kohl M, Teo KK, Heinze G, Dehghan M, Clase CM, Gao P, Yusuf S, Mann JF, Oberbauer R. Dietary risk factors for incidence or progression of chronic kidney disease in individuals with type 2 diabetes in the European Union. Nephrol Dial Transplant. 2015 Aug;30 Suppl 4:iv76-85. doi: 10.1093/ndt/gfv086.

ReferenceCitation: Bohm M, Schumacher H, Leong D, Mancia G, Unger T, Schmieder R, Custodis F, Diener HC, Laufs U, Lonn E, Sliwa K, Teo K, Fagard R, Redon J, Sleight P, Anderson C, O'Donnell M, Yusuf S. Systolic blood pressure variation and mean heart rate is associated with cognitive dysfunction in patients with high cardiovascular risk. Hypertension. 2015 Mar;65(3):651-61. doi: 10.1161/HYPERTENSIONAHA.114.04568. Epub 2015 Jan 12.

ReferenceCitation: Verdecchia P, Reboldi G, Angeli F, Trimarco B, Mancia G, Pogue J, Gao P, Sleight P, Teo K, Yusuf S. Systolic and diastolic blood pressure changes in relation with myocardial infarction and stroke in patients with coronary artery disease. Hypertension. 2015 Jan;65(1):108-14. doi: 10.1161/HYPERTENSIONAHA.114.04310. Epub 2014 Oct 20.

ReferenceCitation: Lonn EM, Rambihar S, Gao P, Custodis FF, Sliwa K, Teo KK, Yusuf S, Bohm M. Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND. Clin Res Cardiol. 2014 Feb;103(2):149-59. doi: 10.1007/s00392-013-0644-4. Epub 2013 Dec 20.

ReferenceCitation: Heerspink HJ, Gao P, de Zeeuw D, Clase C, Dagenais GR, Sleight P, Lonn E, Teo KT, Yusuf S, Mann JF. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial. Eur J Prev Cardiol. 2014 Mar;21(3):299-309. doi: 10.1177/2047487313510678. Epub 2013 Nov 4.

ReferenceCitation: Dunkler D, Dehghan M, Teo KK, Heinze G, Gao P, Kohl M, Clase CM, Mann JF, Yusuf S, Oberbauer R; ONTARGET Investigators. Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus. JAMA Intern Med. 2013 Oct 14;173(18):1682-92. doi: 10.1001/jamainternmed.2013.9051.

ReferenceCitation: Bohm M, Schumacher H, Laufs U, Sleight P, Schmieder R, Unger T, Teo K, Yusuf S. Effects of nonpersistence with medication on outcomes in high-risk patients with cardiovascular disease. Am Heart J. 2013 Aug;166(2):306-314.e7. doi: 10.1016/j.ahj.2013.04.016. Epub 2013 Jun 24.

ReferenceCitation: Dehghan M, Mente A, Teo KK, Gao P, Sleight P, Dagenais G, Avezum A, Probstfield JL, Dans T, Yusuf S; Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET)/Telmisartan Randomized Assessment Study in ACEI Intolerant Subjects With Cardiovascular Disease (TRANSCEND) Trial Investigators. Relationship between healthy diet and risk of cardiovascular disease among patients on drug therapies for secondary prevention: a prospective cohort study of 31 546 high-risk individuals from 40 countries. Circulation. 2012 Dec 4;126(23):2705-12. doi: 10.1161/CIRCULATIONAHA.112.103234.

ReferenceCitation: Barzilay JI, Gao P, Clase CM, Mente A, Mann JF, Sleight P, Yusuf S, Teo KK; OnTARGET/TRANSCEND Investigators. Albuminuria and rapid loss of GFR and risk of new hip and pelvic fractures. Clin J Am Soc Nephrol. 2013 Feb;8(2):233-40. doi: 10.2215/CJN.06640712. Epub 2012 Nov 26.

ReferenceCitation: Kappert K, Bohm M, Schmieder R, Schumacher H, Teo K, Yusuf S, Sleight P, Unger T; ONTARGET/TRANSCEND Investigators. Impact of sex on cardiovascular outcome in patients at high cardiovascular risk: analysis of the Telmisartan Randomized Assessment Study in ACE-Intolerant Subjects With Cardiovascular Disease (TRANSCEND) and the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET). Circulation. 2012 Aug 21;126(8):934-41. doi: 10.1161/CIRCULATIONAHA.111.086660. Epub 2012 Jul 24.

ReferenceCitation: Neumann I, Grassi B. [Critically appraised article]. Rev Med Chil. 2012 Jan;140(1):117-20. Epub 2012 Apr 12. Spanish.

ReferenceCitation: Verdecchia P, Dagenais G, Healey J, Gao P, Dans AL, Chazova I, Binbrek AS, Iacobellis G, Ferreira R, Holwerda N, Karatzas N, Keltai M, Mancia G, Sleight P, Teo K, Yusuf S; Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint TrialTelmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease Investigators. Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies. J Hypertens. 2012 May;30(5):1004-14. doi: 10.1097/HJH.0b013e3283522a51.

ReferenceCitation: Redon J, Mancia G, Sleight P, Schumacher H, Gao P, Pogue J, Fagard R, Verdecchia P, Weber M, Bohm M, Williams B, Yusoff K, Teo K, Yusuf S; ONTARGET Investigators. Safety and efficacy of low blood pressures among patients with diabetes: subgroup analyses from the ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial). J Am Coll Cardiol. 2012 Jan 3;59(1):74-83. doi: 10.1016/j.jacc.2011.09.040.

ReferenceCitation: Mancia G, Schumacher H, Redon J, Verdecchia P, Schmieder R, Jennings G, Yusoff K, Ryden L, Liu GL, Teo K, Sleight P, Yusuf S. Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET). Circulation. 2011 Oct 18;124(16):1727-36. doi: 10.1161/CIRCULATIONAHA.110.008870. Epub 2011 Sep 26.

ReferenceCitation: Barzilay JI, Gao P, Ryden L, Schumacher H, Probstfield J, Commerford P, Dans A, Ferreira R, Keltai M, Paolasso E, Yusuf S, Teo K; TRANSCEND Investigators. Effects of telmisartan on glucose levels in people at high risk for cardiovascular disease but free from diabetes: the TRANSCEND study. Diabetes Care. 2011 Sep;34(9):1902-7. doi: 10.2337/dc11-0545. Epub 2011 Jul 25.

ReferenceCitation: Tobe SW, Clase CM, Gao P, McQueen M, Grosshennig A, Wang X, Teo KK, Yusuf S, Mann JF; ONTARGET and TRANSCEND Investigators. Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies. Circulation. 2011 Mar 15;123(10):1098-107. doi: 10.1161/CIRCULATIONAHA.110.964171. Epub 2011 Feb 28.

ReferenceCitation: Barzilay JI, Gao P, O'Donnell M, Mann JF, Anderson C, Fagard R, Probstfield J, Dagenais GR, Teo K, Yusuf S; ONTARGET and TRANSCEND Investigators. Albuminuria and decline in cognitive function: The ONTARGET/TRANSCEND studies. Arch Intern Med. 2011 Jan 24;171(2):142-50. doi: 10.1001/archinternmed.2010.502.

ReferenceCitation: Dans AL, Teo K, Gao P, Chen JH, Jae-Hyung K, Yusoff K, Chaithiraphan S, Zhu J, Lisheng L, Yusuf S; Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial Investigators. In a subgroup of high-risk Asians, telmisartan was non-inferior to ramipril and better tolerated in the prevention of cardiovascular events. PLoS One. 2010 Dec 21;5(12):e13694. doi: 10.1371/journal.pone.0013694.

ReferenceCitation: Anderson C, Teo K, Gao P, Arima H, Dans A, Unger T, Commerford P, Dyal L, Schumacher H, Pogue J, Paolasso E, Holwerda N, Chazova I, Binbrek A, Young J, Yusuf S; ONTARGET and TRANSCEND Investigators. Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies. Lancet Neurol. 2011 Jan;10(1):43-53. doi: 10.1016/S1474-4422(10)70250-7. Epub 2010 Oct 25.

ReferenceCitation: Bohm M, Baumhakel M, Teo K, Sleight P, Probstfield J, Gao P, Mann JF, Diaz R, Dagenais GR, Jennings GL, Liu L, Jansky P, Yusuf S; ONTARGET/TRANSCEND Erectile Dysfunction Substudy Investigators. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials. Circulation. 2010 Mar 30;121(12):1439-46. doi: 10.1161/CIRCULATIONAHA.109.864199. Epub 2010 Mar 15.

ReferenceCitation: Verdecchia P, Sleight P, Mancia G, Fagard R, Trimarco B, Schmieder RE, Kim JH, Jennings G, Jansky P, Chen JH, Liu L, Gao P, Probstfield J, Teo K, Yusuf S; ONTARGET/TRANSCEND Investigators. Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease. Circulation. 2009 Oct 6;120(14):1380-9. doi: 10.1161/CIRCULATIONAHA.109.865774. Epub 2009 Sep 21.

ReferenceCitation: Sleight P, Redon J, Verdecchia P, Mancia G, Gao P, Fagard R, Schumacher H, Weber M, Bohm M, Williams B, Pogue J, Koon T, Yusuf S; ONTARGET investigators. Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens. 2009 Jul;27(7):1360-9. doi: 10.1097/HJH.0b013e32832d7370.

ReferenceCitation: Mann JF, Schmieder RE, Dyal L, McQueen MJ, Schumacher H, Pogue J, Wang X, Probstfield JL, Avezum A, Cardona-Munoz E, Dagenais GR, Diaz R, Fodor G, Maillon JM, Ryden L, Yu CM, Teo KK, Yusuf S; TRANSCEND (Telmisartan Randomised Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease) Investigators. Effect of telmisartan on renal outcomes: a randomized trial. Ann Intern Med. 2009 Jul 7;151(1):1-10, W1-2. doi: 10.7326/0003-4819-151-1-200907070-00122. Epub 2009 May 18.

ReferenceCitation: Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators; Yusuf S, Teo K, Anderson C, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Epub 2008 Aug 29. Erratum In: Lancet. 2008 Oct 18;372(9647):1384.

ReferenceCitation: Mann JF, Schmieder RE, McQueen M, Dyal L, Schumacher H, Pogue J, Wang X, Maggioni A, Budaj A, Chaithiraphan S, Dickstein K, Keltai M, Metsarinne K, Oto A, Parkhomenko A, Piegas LS, Svendsen TL, Teo KK, Yusuf S; ONTARGET investigators. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. Lancet. 2008 Aug 16;372(9638):547-53. doi: 10.1016/S0140-6736(08)61236-2.

ReferenceCitation: ONTARGET Investigators; Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31.

ReferenceCitation: Held C, Gerstein HC, Yusuf S, Zhao F, Hilbrich L, Anderson C, Sleight P, Teo K; ONTARGET/TRANSCEND Investigators. Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk. Circulation. 2007 Mar 20;115(11):1371-5. doi: 10.1161/CIRCULATIONAHA.106.661405. Epub 2007 Mar 5.

location_country:
Finland
Germany
Ireland
Poland
New Zealand
Argentina
Australia
Brazil
Thailand
Turkey
Canada
France
Czech Republic
Portugal
Slovakia
Hungary
Hong Kong
Denmark
Switzerland
United States
Ukraine
Belgium
China
Malaysia
Puerto Rico
Philippines
Italy
Norway
Singapore
United Kingdom
Netherlands
Austria
Mexico
United Arab Emirates
Korea, Republic of
Spain
Greece
South Africa
Taiwan
Russian Federation
Sweden

location_facility: 502.373.1239 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1488 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0630 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0805 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0239 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0077 Health Science Centre Diabetes Research Group

location_facility: 502.373.1144 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1460 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1004 Boehringer Ingelheim Investigational Site

location_facility: 502.373.423 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1234 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0523 The Prince Charles Hospital

location_facility: 502.373.0731 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1367 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1629 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1322 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0258 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0183 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0231 Boehringer Ingelheim Investigational Site

location_facility: 502.373.2707 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0081 Centre de recherche clinique, CUSE 3001

location_facility: 502.373.1319 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1311 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1481 Boehringer Ingelheim Investigational Site

location_facility: 502.373.378 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1458 Boehringer Ingelheim Investigational Site

location_facility: 502.373.408 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0178 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1634 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1126 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0033 Clinique de Cardiologie de Levis

location_facility: 502.373.1076 Cabinet Médical La Grande Ramée

location_facility: 502.373.377 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1210 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0177 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0068 SDRI - University of Saskatchewan

location_facility: 502.373.0739 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0195 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0619 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1160 Boehringer Ingelheim Investigational Site

location_facility: 502.373.360 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1656 Baskent Universitesi Tip Fakultesi

location_facility: 502.373.0067 SDRI - University of Saskatchewan

location_facility: 502.373.1731 Boehringer Ingelheim Investigational Site

location_facility: 502.373.355 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0026 Centre hospitalier Pierre-Le Gardeur

location_facility: 502.373.0632 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1375 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1432 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1584 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1243 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0804 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1591 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0631 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1161 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0456 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1018 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0537 Austin & Repatriation Medical Centre

location_facility: 502.373.1166 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0530 Sir Charles Gairdner Hospital

location_facility: 502.373.0628 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0247 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1231 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0243 Boehringer Ingelheim Investigational Site

location_facility: 502.373.353 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0252 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0626 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1356 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1235 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1457 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0223 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0238 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1254 Ospedale di Città della Pieve

location_facility: 502.373.1214 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0203 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0282 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1364 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0044 Mississauga Clinical Research Centre

location_facility: 502.373.1237 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0521 Princess Alexandra Hospital

location_facility: 502.373.414 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1155 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1002 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1728 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1301 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1433 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0039 Scarborough Cardiology Research

location_facility: 502.373.0680 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0470 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1011 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1305 Boehringer Ingelheim Investigational Site

location_facility: 502.373.410 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0676 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1318 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0162 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0187 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1150 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1360 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0273 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0226 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0002 Penticton Regional Hospital

location_facility: 502.373.0070 SDRI - University of Saskatchewan

location_facility: 502.373.0249 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1055 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0228 Boehringer Ingelheim Investigational Site

location_facility: 502.373.426 Boehringer Ingelheim Investigational Site

location_facility: 502.373.425 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0753 Boehringer Ingelheim Investigational Site

location_facility: 502.373.371 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0029 Riverside Professional Building

location_facility: 502.373.0783 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0806 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1163 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0245 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0208 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0677 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1730 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1698 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0529 Launceston General Hospital

location_facility: 502.373.0764 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1703 Boehringer Ingelheim Investigational Site

location_facility: 502.373.350 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1655 Cerrahpasa Universitesi Tip Fakultesi

location_facility: 502.373.424 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1357 Boehringer Ingelheim Investigational Site

location_facility: 502.373.357 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0256 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0266 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0763 Boehringer Ingelheim Investigational Site

location_facility: 502.373.362 Boehringer Ingelheim Investigational Site

location_facility: 502.373.358 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1579 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0776 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1204 Boehringer Ingelheim Investigational Site

location_facility: 502.373.376 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1314 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1236 Boehringer Ingelheim Investigational Site

location_facility: 502.373.420 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1309 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0082 3U4, McMaster University Medical Centre

location_facility: 502.373.1125 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0808 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1370 Boehringer Ingelheim Investigational Site

location_facility: 502.373.361 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0199 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1266 Azienda Universitaria Policlinico "Federico II"

location_facility: 502.373.0460 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1585 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1136 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1729 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0264 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1140 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0023 Group Health Centre - Clinical Trials

location_facility: 502.373.1164 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0268 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1162 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1228 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1313 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1650 Erciyes Universitesi Tip Fakultesi Kardiyoloji Anabilim Dali

location_facility: 502.373.1487 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1129 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1708 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1408 Hospitais da Universidade de Coimbra

location_facility: 502.373.0614 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1017 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1000 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1201 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1147 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0536 Royal Prince Alfred Hospital

location_facility: 502.373.0011 St. Joseph's Hospital Cardiac Research

location_facility: 502.373.1597 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1553 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0288 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1361 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1304 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0086 Via Car Recherche Clinique Inc

location_facility: 502.373.20003 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1562 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1706 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1205 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1473 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1007 Boehringer Ingelheim Investigational Site

location_facility: 502.373.60001 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0526 Peninsula Clinical Research Centre

location_facility: 502.373.0267 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0782 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0051 Merivale Cardiovascular Consultants

location_facility: 502.373.0778 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0270 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0451 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0055 Specialists - Internal Medicine

location_facility: 502.373.0781 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0173 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1427 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0031 Brampton Research Associates

location_facility: 502.373.1128 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1137 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1300 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1633 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1138 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1224 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0544 Coffs Harbour Cardiovascular Clinic

location_facility: 502.373.1310 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0046 Interior Clinical Research Consultants Ltd

location_facility: 502.373.415 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1303 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1354 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1430 Boehringer Ingelheim Investigational Site

location_facility: 502.373.20005 Sykehuset i Vestfold, Avd. Tønsberg

location_facility: 502.373.1631 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1705 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0535 The Prince of Wales Hospital

location_facility: 502.373.1056 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1639 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1167 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1252 Azienda Ospedaliera di Caserta

location_facility: 502.373.1598 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1132 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1062 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0775 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1148 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0193 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1015 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0191 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0003 Discovery Clinical Services Ltd

location_facility: 502.373.1632 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0234 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1559 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0061 CLIKS Medical Research Corp

location_facility: 502.373.1701 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1021 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1019 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0057 Centre De Recherche Clinique

location_facility: 502.373.1135 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0169 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1127 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1152 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0168 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0754 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0617 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0174 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1590 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0042 Sunnybrook & Woman's College Health Science Centre

location_facility: 502.373.1358 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1133 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1557 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0601 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0066 SDRI - University of Saskatchewan

location_facility: 502.373.1714 Dept. of Clinical Pharmacology

location_facility: 502.373.0604 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1206 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0756 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1470 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0760 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1583 Boehringer Ingelheim Investigational Site

location_facility: 502.373.367 Boehringer Ingelheim Investigational Site

location_facility: 502.373.373 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0164 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1317 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0027 Ctr Hospitalier Beauce Etchemin

location_facility: 502.373.1321 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1702 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1540 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1700 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0503 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0733 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0155 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0634 Boehringer Ingelheim Investigational Site

location_facility: 502.373.406 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1475 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0190 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0166 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1060 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1256 Ospedale Civile SS. Annunziata - USL 1

location_facility: 502.373.1226 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1229 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0286 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1273 A.O. "S. Camillo de Lellis"

location_facility: 502.373.1545 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1697 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1010 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0801 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0271 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1452 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0158 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0611 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1563 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1555 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0605 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1230 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1363 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1003 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0629 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1020 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0615 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1227 Boehringer Ingelheim Investigational Site

location_facility: 502.373.411 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0237 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1233 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0217 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1149 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1261 Ospedale Civile di Casarano

location_facility: 502.373.403 Boehringer Ingelheim Investigational Site

location_facility: 502.373.369 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0185 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1560 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1232 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1203 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1734 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0001 C849 Division of Cardiology, Foothills Medical Centre

location_facility: 502.373.417 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1351 Boehringer Ingelheim Investigational Site

location_facility: 502.373.405 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1312 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0014 Via Car Recherche Clinique Inc

location_facility: 502.373.1308 Boehringer Ingelheim Investigational Site

location_facility: 502.373.416 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1240 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0559 St George Hospital - Dept of Clinical Pharmacology

location_facility: 502.373.1158 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1061 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0180 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1596 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0736 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0157 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0625 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1726 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1014 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0623 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1558 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1599 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0024 London HSC - University Hospital

location_facility: 502.373.1707 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1244 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1556 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0262 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0616 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0704 National Kidney & Transplant Institute, Room 821

location_facility: 502.373.1277 A.S.O. "S. Giovanni Battista"

location_facility: 502.373.1352 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0172 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1302 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1653 Ankara Hastanesi Endokrinoloji Bölümü

location_facility: 502.373.1431 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0181 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0702 De La Salle University Medical Center

location_facility: 502.373.0154 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1461 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1471 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0750 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1593 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0054 Orleans Medical-Dental Centre

location_facility: 502.373.0624 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0156 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0500 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1141 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0150 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0459 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0215 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1459 Boehringer Ingelheim Investigational Site

location_facility: 502.373.352 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0506 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0274 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1272 Ospedale di Circolo di Varese

location_facility: 502.373.1401 Unidade Local de Saúde de Matosinhos

location_facility: 502.373.407 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1592 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0232 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0080 Polyclinique vasculaire Centre hospitalier universitaire de

location_facility: 502.373.0254 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1425 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1551 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1208 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1675 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1153 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0610 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1454 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1139 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1211 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1725 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0701 Manila Doctors Hospital, Room 3 Annex

location_facility: 502.373.1320 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0248 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1692 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1564 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0161 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0450 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1578 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1131 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1733 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1594 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1538 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0281 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0457 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0012 Hopital Laval - Institute Cardiologie de Quebec

location_facility: 502.373.412 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0726 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1691 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0171 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1651 Cukurova Universitesi Tip Fakultesi

location_facility: 502.373.1146 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0618 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1529 Boehringer Ingelheim Investigational Site

location_facility: 502.373.374 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1575 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1719 Pulmonary Function Laboratory

location_facility: 502.373.1372 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1576 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0620 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0780 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1058 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1028 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0621 Boehringer Ingelheim Investigational Site

location_facility: 502.373.366 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1362 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0275 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1225 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0757 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0454 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1323 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0213 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0779 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1554 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1426 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1695 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0284 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1200 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0755 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0603 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0227 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0551 Port Lincoln "The Investigator" Clinic

location_facility: 502.373.0734 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0272 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0279 Boehringer Ingelheim Investigational Site

location_facility: 502.373.375 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1242 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1202 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1710 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1053 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1078 Cabinet Médical des Tanneurs

location_facility: 502.373.1156 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1355 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1406 Hospital Distrital de Faro Geral

location_facility: 502.373.1369 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1253 Istituto di Ricovero a Carattere Scientifico Neuromed- IRCCS

location_facility: 502.373.0504 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1586 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1509 Hjärtsektionen / Med.kliniken

location_facility: 502.373.0214 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0230 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1677 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0532 Baker Medical Research Centre

location_facility: 502.373.0222 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1696 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1005 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0153 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1209 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1679 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0280 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0159 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1315 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1006 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0188 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0761 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0207 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0627 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1376 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1359 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0550 Repatriation General Hospital

location_facility: 502.373.0152 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0622 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0725 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1550 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0076 Centre Hospitalier de Vallees de l'Outaouais Gatineau

location_facility: 502.373.0681 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1374 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1595 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0549 Illawarra Regional Hospital

location_facility: 502.373.1690 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0206 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1165 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1207 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0458 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1580 Boehringer Ingelheim Investigational Site

location_facility: 502.373.422 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1057 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0189 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0163 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0184 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0461 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1479 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0032 New Market Cardiology Research Grp

location_facility: 502.373.0807 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0219 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1241 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0259 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1009 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1092 Cabinet Médical de St Pierre

location_facility: 502.373.0212 Boehringer Ingelheim Investigational Site

location_facility: 502.373.400 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1450 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1485 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0453 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0240 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1265 IRCCS - Policlinico S. Matteo

location_facility: 502.373.1316 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0607 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1373 Boehringer Ingelheim Investigational Site

location_facility: 502.373.365 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1134 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1353 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0175 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1051 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1709 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0502 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1238 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0608 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0205 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1456 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0201 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0037 Niagara Falls Medical Centre

location_facility: 502.373.0244 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1264 Presidio Ospedaliero "Villa Sofia"

location_facility: 502.373.1659 Ankara Universitesi Tip Fakultesi

location_facility: 502.373.421 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1601 Boehringer Ingelheim Investigational Site

location_facility: 502.373.354 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1154 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1267 Azienda Universitaria Policlinico II

location_facility: 502.373.1582 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0229 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0251 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0277 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1213 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1699 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1693 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0539 Central Coast Neuroscience Research

location_facility: 502.373.1627 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0606 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1022 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0084 CHA-Hopital de l'Efant-Jesus

location_facility: 502.373.0777 Boehringer Ingelheim Investigational Site

location_facility: 502.373.351 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0209 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1157 Boehringer Ingelheim Investigational Site

location_facility: 502.373.418 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0165 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0241 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0613 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0283 Boehringer Ingelheim Investigational Site

location_facility: 502.373.364 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0179 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1552 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1059 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1637 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1694 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0261 Boehringer Ingelheim Investigational Site

location_facility: 502.373.402 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0452 Boehringer Ingelheim Investigational Site

location_facility: 502.373.413 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1486 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0612 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0685 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1307 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1652 Cukurova Universitesi Tip Fakultesi

location_facility: 502.373.356 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0025 Hopital Maisonneuve Rosemont

location_facility: 502.373.1455 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1025 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1365 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1625 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1589 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0538 Concord Repatriation General Hospital

location_facility: 502.373.0265 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1275 A.O. Spedali Civili di Brescia -Univ. degli studi di Brescia

location_facility: 502.373.1658 Ege Universitesi Tip Fakultesi

location_facility: 502.373.1680 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0700 Philippine General Hospital

location_facility: 502.373.1451 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1654 Göztepe SSK Egitim ve Arastirma Hastanesi

location_facility: 502.373.1366 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0167 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0803 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1628 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1368 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1429 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1732 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1453 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0602 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1255 Ospedale "S. Orsola Malpighi"

location_facility: 502.373.0802 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1407 Centro Hospitalar vila Nova de Gaia

location_facility: 502.373.419 Boehringer Ingelheim Investigational Site

location_facility: 502.373.404 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1428 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1577 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1561 Boehringer Ingelheim Investigational Site

location_facility: 502.373.2706 Boehringer Ingelheim Investigational Site

location_facility: 502.373.409 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0732 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1704 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1727 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1159 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0182 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1142 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0198 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1535 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0202 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0633 Boehringer Ingelheim Investigational Site

location_facility: 502.373.1145 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0507 Boehringer Ingelheim Investigational Site

location_facility: 502.373.0221 Boehringer Ingelheim Investigational Site


title: ECASS III - European Cooperative Acute Stroke Study III: A Placebo Controlled Trial of Alteplase (Rt-PA) in Acute Ischemic Hemispheric Stroke Where Thrombolysis is Initiated Between 3 and 4 Hours 30 Minutes After Stroke Onset

summary: To collect additional confirmatory data on alteplase(rt-PA) in the European setting and to demonstrate that the treatment of patients between 3 and 4.30 hours of onset of symptoms of acute ischemic stroke with rt-PA compared to placebo-treated patients will result in an improved clinical outcome without increase of fatality rate.

status: Completed

study_type: Interventional

primary_purpose: Treatment

enrollment_type: Actual

ReferenceType: derived

ReferenceCitation: Alper BS, Foster G, Thabane L, Rae-Grant A, Malone-Moses M, Manheimer E. Thrombolysis with alteplase 3-4.5 hours after acute ischaemic stroke: trial reanalysis adjusted for baseline imbalances. BMJ Evid Based Med. 2020 Oct;25(5):168-171. doi: 10.1136/bmjebm-2020-111386. Epub 2020 May 19.

oa_host_type: publisher;repository

evidence: open (via page says license)

host_type: publisher

license: cc-by-nc

license_normalized: cc-by-nc

version: publishedVersion

evidence: oa repository (via pmcid lookup)

host_type: repository

license_normalized: no license

repository_normalized: PubMed Central

repositories_concat: PubMed Central

unpaywall_oa_status: hybrid

publisher_dissemination: British Medical Journal

ReferenceCitation: Bluhmki E, Chamorro A, Davalos A, Machnig T, Sauce C, Wahlgren N, Wardlaw J, Hacke W. Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial. Lancet Neurol. 2009 Dec;8(12):1095-102. doi: 10.1016/S1474-4422(09)70264-9. Epub 2009 Oct 21.

ReferenceCitation: Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008 Sep 25;359(13):1317-29. doi: 10.1056/NEJMoa0804656.

lead_sponsor: Boehringer Ingelheim

location_country:
Finland
Germany
Poland
France
Czech Republic
Portugal
Slovakia
Hungary
Denmark
Switzerland
Belgium
Italy
Norway
United Kingdom
Netherlands
Austria
Spain
Greece
Sweden

location_facility: 135.312.43003 Boehringer Ingelheim Investigational Site

location_facility: 135.312.32014 Boehringer Ingelheim Investigational Site

location_facility: 135.312.39019 Ospedale Santa Maria Annunziata

location_facility: 135.312.44018 Boehringer Ingelheim Investigational Site

location_facility: 135.312.42002 Boehringer Ingelheim Investigational Site

location_facility: 135.312.33004 Boehringer Ingelheim Investigational Site

location_facility: 135.312.34011 Boehringer Ingelheim Investigational Site

location_facility: 135.312.49020 Boehringer Ingelheim Investigational Site

location_facility: 135.312.33017 Boehringer Ingelheim Investigational Site

location_facility: 135.312.41001 Boehringer Ingelheim Investigational Site

location_facility: 135.312.34010 Boehringer Ingelheim Investigational Site

location_facility: 135.312.43008 Boehringer Ingelheim Investigational Site

location_facility: 135.312.45004 Boehringer Ingelheim Investigational Site

location_facility: 135.312.33014 Boehringer Ingelheim Investigational Site

location_facility: 135.312.39025 Università di Roma "La Sapienza"

location_facility: 135.312.33001 Boehringer Ingelheim Investigational Site

location_facility: 135.312.44006 Boehringer Ingelheim Investigational Site

location_facility: 135.312.44030 Boehringer Ingelheim Investigational Site

location_facility: 135.312.33022 Boehringer Ingelheim Investigational Site

location_facility: 135.312.39009 Ospedale Maggiore di BorgoTrento

location_facility: 135.312.35802 Boehringer Ingelheim Investigational Site

location_facility: 135.312.33024 Boehringer Ingelheim Investigational Site

location_facility: 135.312.43012 Boehringer Ingelheim Investigational Site

location_facility: 135.312.34006 Boehringer Ingelheim Investigational Site

location_facility: 135.312.48004 Medical University of Gdansk

location_facility: 135.312.44026 Boehringer Ingelheim Investigational Site

location_facility: 135.312.49005 Boehringer Ingelheim Investigational Site

location_facility: 135.312.36001 Aladár Petz County Hospital

location_facility: 135.312.33019 Boehringer Ingelheim Investigational Site

location_facility: 135.312.49002 Boehringer Ingelheim Investigational Site

location_facility: 135.312.33005 Boehringer Ingelheim Investigational Site

location_facility: 135.312.46002 Boehringer Ingelheim Investigational Site

location_facility: 135.312.44003 Boehringer Ingelheim Investigational Site

location_facility: 135.312.49008 Boehringer Ingelheim Investigational Site

location_facility: 135.312.49017 Boehringer Ingelheim Investigational Site

location_facility: 135.312.41004 Boehringer Ingelheim Investigational Site

location_facility: 135.312.35805 Boehringer Ingelheim Investigational Site

location_facility: 135.312.43007 Boehringer Ingelheim Investigational Site

location_facility: 135.312.34017 Boehringer Ingelheim Investigational Site

location_facility: 135.312.33020 Boehringer Ingelheim Investigational Site

location_facility: 135.312.45005 Boehringer Ingelheim Investigational Site

location_facility: 135.312.42001 Boehringer Ingelheim Investigational Site

location_facility: 135.312.49023 Boehringer Ingelheim Investigational Site

location_facility: 135.312.30005 Boehringer Ingelheim Investigational Site

location_facility: 135.312.34009 Boehringer Ingelheim Investigational Site

location_facility: 135.312.34014 Boehringer Ingelheim Investigational Site

location_facility: 135.312.49006 Boehringer Ingelheim Investigational Site

location_facility: 135.312.46007 Boehringer Ingelheim Investigational Site

location_facility: 135.312.43010 Boehringer Ingelheim Investigational Site

location_facility: 135.312.33015 Boehringer Ingelheim Investigational Site

location_facility: 135.312.49037 Boehringer Ingelheim Investigational Site

location_facility: 135.312.49011 Boehringer Ingelheim Investigational Site

location_facility: 135.312.35105 Hospital de São Sebastião, EPE

location_facility: 135.312.34002 Boehringer Ingelheim Investigational Site

location_facility: 135.312.34020 Boehringer Ingelheim Investigational Site

location_facility: 135.312.43002 Boehringer Ingelheim Investigational Site

location_facility: 135.312.33018 Boehringer Ingelheim Investigational Site

location_facility: 135.312.45002 Boehringer Ingelheim Investigational Site

location_facility: 135.312.43004 Boehringer Ingelheim Investigational Site

location_facility: 135.312.47001 Boehringer Ingelheim Investigational Site

location_facility: 135.312.49003 Boehringer Ingelheim Investigational Site

location_facility: 135.312.39001 A. O. Policlinico Umberto I

location_facility: 135.312.32016 Boehringer Ingelheim Investigational Site

location_facility: 135.312.41003 Boehringer Ingelheim Investigational Site

location_facility: 135.312.33010 Boehringer Ingelheim Investigational Site

location_facility: 135.312.43013 Boehringer Ingelheim Investigational Site

location_facility: 135.312.49038 Boehringer Ingelheim Investigational Site

location_facility: 135.312.33008 Boehringer Ingelheim Investigational Site

location_facility: 135.312.49041 Boehringer Ingelheim Investigational Site

location_facility: 135.312.48001 Institute of Psychiatry & Neurology in Warsaw

location_facility: 135.312.33009 Boehringer Ingelheim Investigational Site

location_facility: 135.312.33002 Boehringer Ingelheim Investigational Site

location_facility: 135.312.44002 Boehringer Ingelheim Investigational Site

location_facility: 135.312.42105 Boehringer Ingelheim Investigational Site

location_facility: 135.312.44024 Boehringer Ingelheim Investigational Site

location_facility: 135.312.46003 Boehringer Ingelheim Investigational Site

location_facility: 135.312.32005 Boehringer Ingelheim Investigational Site

location_facility: 135.312.34003 Boehringer Ingelheim Investigational Site

location_facility: 135.312.33023 Boehringer Ingelheim Investigational Site

location_facility: 135.312.36006 BAZ County and Teaching Hospital

location_facility: 135.312.39016 A. O. Ospedale Santa Corona

location_facility: 135.312.44025 Boehringer Ingelheim Investigational Site

location_facility: 135.312.34007 Boehringer Ingelheim Investigational Site

location_facility: 135.312.48006 Wojewodship Specialistic Neuropsychiatric Centre in Opole

location_facility: 135.312.33013 Boehringer Ingelheim Investigational Site

location_facility: 135.312.30002 Boehringer Ingelheim Investigational Site

location_facility: 135.312.46005 Boehringer Ingelheim Investigational Site

location_facility: 135.312.33012 Boehringer Ingelheim Investigational Site

location_facility: 135.312.43001 Boehringer Ingelheim Investigational Site

location_facility: 135.312.43006 Boehringer Ingelheim Investigational Site

location_facility: 135.312.35801 Boehringer Ingelheim Investigational Site

location_facility: 135.312.30004 Boehringer Ingelheim Investigational Site

location_facility: 135.312.47003 Boehringer Ingelheim Investigational Site

location_facility: 135.312.32002 Boehringer Ingelheim Investigational Site

location_facility: 135.312.33006 Boehringer Ingelheim Investigational Site

location_facility: 135.312.34018 Boehringer Ingelheim Investigational Site

location_facility: 135.312.47006 Boehringer Ingelheim Investigational Site

location_facility: 135.312.39013 A. O. Universitaria di Careggi

location_facility: 135.312.33007 Boehringer Ingelheim Investigational Site

location_facility: 135.312.49014 Boehringer Ingelheim Investigational Site

location_facility: 135.312.41002 Boehringer Ingelheim Investigational Site

location_facility: 135.312.33021 Boehringer Ingelheim Investigational Site

location_facility: 135.312.49018 Boehringer Ingelheim Investigational Site

location_facility: 135.312.34019 Boehringer Ingelheim Investigational Site

location_facility: 135.312.46004 Boehringer Ingelheim Investigational Site

location_facility: 135.312.33011 Boehringer Ingelheim Investigational Site

location_facility: 135.312.39024 Istituto Scientifico San Raffaele

location_facility: 135.312.39018 Ospedale S. Maria della Misericordia

location_facility: 135.312.34001 Boehringer Ingelheim Investigational Site

location_facility: 135.312.49001 Boehringer Ingelheim Investigational Site

location_facility: 135.312.49009 Boehringer Ingelheim Investigational Site

location_facility: 135.312.32001 Boehringer Ingelheim Investigational Site

location_facility: 135.312.42004 Boehringer Ingelheim Investigational Site

location_facility: 135.312.48002 Dr. Anna Gostynska Wolski Hospital

location_facility: 135.312.44023 Boehringer Ingelheim Investigational Site

location_facility: 135.312.32011 Boehringer Ingelheim Investigational Site

location_facility: 135.312.33003 Boehringer Ingelheim Investigational Site

location_facility: 135.312.39002 A. O. di Padova - Policlinico Universitario

location_facility: 135.312.42104 Jessenius Faculty of Medicine Commenius University

location_facility: 135.312.33016 Boehringer Ingelheim Investigational Site

location_facility: 135.312.39005 A. O. di Perugia - Policlinico Monteluce

location_facility: 135.312.49004 Boehringer Ingelheim Investigational Site

location_facility: 135.312.39003 A. O. Arcispedale "Santa Maria Nuova"

location_facility: 135.312.48005 Dept. of Neurology, Regenerative and Cerebrovascular Disease

location_facility: 135.312.45001 Boehringer Ingelheim Investigational Site

location_facility: 135.312.49025 Boehringer Ingelheim Investigational Site

location_facility: 135.312.35101 Hospitais da Universidade de Coimbra

location_facility: 135.312.49031 Boehringer Ingelheim Investigational Site

intervention_type: Drug

lead_sponsor_type: industriel

status_simplified: Completed


title: A Long Term Open Label Rollover Trial Assessing the Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV-1 Infected Subjects

summary: The objective of this study is to determine the long term safety and tolerability of multiple oral doses of tipranavir (Aptivus) and ritonavir with a focus on the long term safety of the development dose (500 mg tipranavir/200 mg ritonavir BID) when administered with other antiretroviral medications.

design_allocation: Non-Randomized

location_country:
Germany
Italy
Portugal
United Kingdom
Argentina
Denmark
Australia
Brazil
Netherlands
Austria
Belgium
Mexico
United States
Spain
Switzerland
Greece
Canada
France

location_facility: 1182.17.0384 Azienda Ospedaliera Arcispedale S. Anna

location_facility: 1182.17.4103 DIM / Abteilung für Infektiologie

location_facility: 1182.17.103 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.5 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.4418 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.0393 Fondazione Centro S. Raffaele del Monte Tabor

location_facility: 1182.17.129 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.31 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.5406 Pabellón de Clínicas 2° Piso

location_facility: 1182.17.714 Hospital General Universitario de Valencia

location_facility: 1182.17.402 Taylor Square Private Clinic

location_facility: 1182.17.60 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.0395 Azienda Policlinico Umberto I

location_facility: 1182.17.5203 Hospital Civil Nuevo de Guadalajara

location_facility: 1182.17.0409 Ospedale Santa Maria Annunziata

location_facility: 1182.17.53 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.907 University Health Network - Toronto General Hospital

location_facility: 1182.17.5506 Centro de Referência e Treinamento - DST/AIDS

location_facility: 1182.17.73 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.4920 Abteilung Klinische Immunologie

location_facility: 1182.17.0411 Presidio Ospedaliero "A. Manzoni"

location_facility: 1182.17.100 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.705 Hospital Germans Trias i Pujol

location_facility: 1182.17.3209 Instituut Tropische Geneeskunde

location_facility: 1182.17.122 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.903 Montreal Chest Institute, McGill University Health Centre

location_facility: 1182.17.47 University of Southern California

location_facility: 1182.17.3502 Hospital Condes Castro Guimarães

location_facility: 1182.17.3002 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.21 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.75 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.4902 Charite, Campus Virchow-Klinikum

location_facility: 1182.17.43 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.111 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.1 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.94 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.92 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.68 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.902 Downtown Infectious Diseases Clinic

location_facility: 1182.17.64 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.5509 (Unidade de Testes Terapêuticos)

location_facility: 1182.17.67 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.18 Vanderbilt AIDS Clinical Trials Center

location_facility: 1182.17.128 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.30 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.4924 Klinikum der J. W.-Goethe-Universität

location_facility: 1182.17.89 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.54 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.99 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.4408 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.23 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.00334 Hôpital de la Pitié Salpêtrière

location_facility: 1182.17.5505 Instituto A-Z de Pesquisa e Ensino da PUC

location_facility: 1182.17.33022 Hôpital Européen Georges Pompidou

location_facility: 1182.17.0419 I Cattedra Malattie Infettive

location_facility: 1182.17.22 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.5503 Instituto de Infectologia Emílio Ribas

location_facility: 1182.17.112 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.36 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.26 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.76 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.15 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.3201 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.4923 Facharzt für Innere Medizin,

location_facility: 1182.17.718 Complejo Hospitalario Xeral - Cíes

location_facility: 1182.17.4102 Departement für Innere Medizin

location_facility: 1182.17.37 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.3003 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.4928 Facharzt für Innere Medizin/Rheumatologie

location_facility: 1182.17.8 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.106 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.904 Clinique Medicale Du Quartier Latin

location_facility: 1182.17.3105 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.701 Hospital Clínico y Provincial de Barcelona

location_facility: 1182.17.46 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.5511 Universidade Federal da Bahia

location_facility: 1182.17.5507 Hospital Geral de Nova Iguaçu - Ministério da Saúde

location_facility: 1182.17.4101 DIM / Abteilung für Infektiologie

location_facility: 1182.17.0385 IRCCS Policlinico San Matteo

location_facility: 1182.17.50 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.4406 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.95 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.24 Hackensack University Medical Center

location_facility: 1182.17.4404 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.4301 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.3 Division of Infectious Diseases

location_facility: 1182.17.3202 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.202 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.910 Sunnybrook & Women's College Health Science Centre

location_facility: 1182.17.93 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.4409 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.70 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.3210 Centre Hospitalier de Luxembourg

location_facility: 1182.17.132 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.77 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.58 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.52 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.914 Montreal General Hospital - McGill University Health Centre

location_facility: 1182.17.125 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.118 Early Intervention Program (EIP) Clinic

location_facility: 1182.17.135 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.74 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.126 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.0394 IRCCS Policlinico San Matteo

location_facility: 1182.17.901 Division of Infectious Diseases

location_facility: 1182.17.10 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.4906 ID-Ambulanz Klinikum Dortmund

location_facility: 1182.17.0413 Ospedale di Circolo di Busto

location_facility: 1182.17.4104 Département de médicine interne Div. Des maladies infectieus

location_facility: 1182.17.65 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.69 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.114 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.86 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.717 Hospital Clínico Universitario Vírgen de la Victoria

location_facility: 1182.17.5405 Dpto. de Enfermedades infecciosas (Pabellón 22)

location_facility: 1182.17.4501 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.3101 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.4405 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.136 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.131 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.9 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.142 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.32 University of Kansas School of Medicine - Wichita

location_facility: 1182.17.7 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.4 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.4916 Medizinisches Versorgungszentrum Hamburg

location_facility: 1182.17.407 Holdsworth House General Practice

location_facility: 1182.17.4411 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.4505 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.5502 Farmácia do Instituto de Pesquisa Evandro Chagas

location_facility: 1182.17.3108 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.130 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.00335 Hôpital Bichat Claude Bernard

location_facility: 1182.17.3009 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.11 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.713 Hospital Universitario Vírgen del Rocío

location_facility: 1182.17.3207 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.96 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.3004 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.115 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.116 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.110 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.6 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.906 Infectious Diseases & HIV - St. Michael's Hospital

location_facility: 1182.17.97 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.87 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.4504 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.4414 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.0415 U.O.A. Malattie Infettive B

location_facility: 1182.17.905 Canadian Immunodeficiency Research Collaborative Inc.

location_facility: 1182.17.63 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.79 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.3007 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.51 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.3010 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.62 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.102 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.59 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.4502 Boehringer Ingelheim Investigational Site

location_facility: 1182.17.913 McMaster University Medical Centre

location_facility: 1182.17.3001 Boehringer Ingelheim Investigational Site